The FDA Safety Act significantly reforms FDA’s inadequate postmarket drug safety program, correcting structural and regulatory shortcomings that have contributed to the agency’s high-profile drug safety failures in recent years.
For 85 years CR has worked for laws and policies that put consumers first. Learn more about CR’s work with policymakers, companies, and consumers to help build a fair and just marketplace at TrustCR.org
The FDA Safety Act significantly reforms FDA’s inadequate postmarket drug safety program, correcting structural and regulatory shortcomings that have contributed to the agency’s high-profile drug safety failures in recent years.